Ishares Msci Spain ETF vs Hinge Health Inc. Class A Common Stock — how do they compare? Ishares Msci Spain ETF trades at $57.9 (market cap $2.31B), while Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B). The key difference: Hinge Health Inc. Class A Common Stock is far larger — about 3.7× Ishares Msci Spain ETF's market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, Ishares Msci Spain ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ishares Msci Spain ETF for 41 Days and Hinge Health Inc. Class A Common Stock for 0 Days on average.
| EWP | HNGE | |
|---|---|---|
Market Cap | $2.31B | $8.48B |
Volume | 302,484 | 879,799 |
Sector | Broad Market / Factor | Health |
52-Week High | $63.23 | $105.14 |
52-Week Low | $48.95 | $31.17 |
Typical Hold Time | 41 Days | 0 Days |
Enterprise Value | — | $8.10B |
Signals from Pluang's Aura AI — not financial advice
EWP trades at $58.34, up 0.52% on the day, with a bearish technical signal driven by moving averages. The stock faces resistance at $59 and support at $58. Key financial ratios are unavailable, limiting fundamental clarity. Recent news highlights European market resilience amid ECB rate hikes and energy-driven inflation pressures.
Outlook is cautious due to bearish technicals and macroeconomic headwinds from ECB tightening. Investment opportunity hinges on Spain's equity valuation appeal, but risks include eurozone economic sentiment slippage and sustained inflation. Investors should await updated financials for fundamental assessment.
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
EWP is a country-specific ETF that tracks the performance of the Spanish equity market. It provides targeted access to large and mid-sized companies in Spain, with heavy weightings in financials and utilities like Banco Santander and Iberdrola.
Read more on EWP →Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →